All lobbying filings
Compass Pathways Inc.
Compass Pathways Inc. filed a Q3 amendment for Compass Pathways Inc. on January 20, 2026.
Lobbying for Compass Pathways Inc. · Biotechnology company
Filing · LD-2 quarterly report
Q3 amendment
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Jan 20, 2026
Expenses
$120,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
New York
Government bodies contacted
3
Lobbying activity
1
Discussions regarding legislative and regulatory issues, including appropriations, pertaining to the use and application of psychedelic medicines.